Skip to main content

Dr Bassel Wattar

Contact Me

Consultancy & Industry Collaboration

Clinical, Academic and Methodological Expertise for Healthcare Innovation
I provide specialist consultancy to organisations developing, evaluating and implementing healthcare interventions and technologies, with particular expertise in women’s health, reproductive medicine and fertility.
I work with academic institutions, pharmaceutical and life-sciences companies, MedTech and FemTech organisations, and healthcare innovators, providing independent clinical and academic expertise across research design, product development and clinical evaluation. This includes assessing clinical need and value, developing evidence-generation strategies, designing clinical studies and advising on the evaluation and implementation of new healthcare technologies.
Academic & Research Consultancy

Research Design and Evidence Generation

I provide academic and methodological consultancy across the research pathway, from the development of a research question through study design, evidence generation, analysis, interpretation and implementation.

Areas in which I can provide support include:

  • Research question development
  • Clinical study design
  • Randomised controlled trial design
  • Systematic reviews and evidence synthesis
  • Meta-analysis and network meta-analysis
  • Diagnostic and prognostic research
  • Real-world evidence studies
  • Outcome selection and measurement
  • Clinical protocol development
  • Health technology assessment
  • Critical appraisal of existing evidence
  • Interpretation of research findings
  • Grant and research programme development
  • Translation of evidence into clinical recommendations
  • Clinical guideline methodology
My focus is on ensuring that research is methodologically robust, clinically relevant and designed to generate evidence that can meaningfully inform clinical practice, policy or healthcare decision-making.
Industry & Pharmaceutical Advisory

Independent Clinical and Academic Input

I work with pharmaceutical, biotechnology, medical-device and healthcare companies to provide independent clinical and scientific advice during the development and evaluation of healthcare interventions.

This can include:

  • Assessment of unmet clinical need
  • Clinical evaluation of new products and technologies
  • Review of product concepts and proposed indications
  • Clinical development strategy
  • Assessment of clinical value
  • Evaluation of existing supporting evidence
  • Study and clinical trial design
  • Selection of clinically meaningful endpoints
  • Evidence-generation strategy
  • Clinical pathway analysis
  • Scientific advisory boards
  • Independent clinical review
  • Regulatory evidence strategy
  • Health technology evaluation
  • mplementation and adoption considerations
Early clinical and methodological input can be particularly useful when defining the target population, intended clinical use, appropriate comparators and outcomes, and the evidence required to support subsequent evaluation.

FemTech & Women's Health Innovation

I have a particular interest in the development and evaluation of technologies addressing unmet needs in women’s health. I work with FemTech, digital-health and medical-device organisations developing products and services across areas including:

This can include:

  • Fertility and assisted conception
  • Reproductive diagnostics
  • Menstrual and reproductive health
  • Polycystic ovary syndrome
  • Endometriosis and adenomyosis
  • Heavy menstrual bleeding
  • Fibroids
  • Menopause
  • Reproductive endocrinology
  • Fertility preservation
  • Digital women's health
  • Women's health diagnostics
  • Medical devices and digital technologies
My role can range from early assessment of the clinical concept and proposed use case through to study design, clinical evaluation and evidence-generation strategy.

Product–Market Fit & Clinical Value

For healthcare technologies, product–market fit requires an understanding not only of the technology itself but also of the clinical problem it is intended to address, the existing care pathway and the alternatives already available to patients and clinicians.

I provide independent clinical assessment of:

  • The unmet clinical need
  • The proposed target population
  • Current standards of care
  • Existing alternatives and competing technologies
  • Position within the clinical pathway
  • Clinical relevance of the proposed product
  • Credibility of proposed clinical claims
  • Potential barriers to clinical adoption
  • Patient acceptability and clinical usability
  • Evidence gaps
  • Appropriate clinical outcomes
  • Evidence required to demonstrate clinical valu
This type of assessment can be undertaken during early product development, before committing to a clinical evaluation programme, or when preparing for regulatory assessment, investment or healthcare adoption.

Health Technology Evaluation & Regulatory Evidence

I provide clinical and methodological advice on the evidence required to evaluate new healthcare interventions and technologies.

This may include:

  • Review and synthesis of existing clinical evidence
  • Identification of evidence gaps
  • Development of clinical evaluation strategies
  • Design of clinical studies and trials
  • Selection of appropriate comparators
  • Selection of clinically meaningful outcomes
  • Development of real-world evidence strategies
  • Assessment of clinical claims
  • Health technology assessment
  • Consideration of evidence requirements for regulatory evaluation
  • Evidence required for healthcare implementation and adoption
Where projects require specialist regulatory, legal or health-economic expertise, I can work alongside the relevant experts as part of a multidisciplinary approach.

Clinical & Scientific Due Diligence

I provide independent clinical and scientific assessment of healthcare technologies for organisations considering investment, collaboration, acquisition or further product development.

This may include assessment of:

  • Scientific plausibility
  • Clinical relevance
  • Unmet clinical need
  • Quality and completeness of existing evidence
  • Validity of clinical claims
  • Target population
  • Current clinical pathway
  • Competitive clinical landscape
  • Proposed clinical studies
  • Evidence-generation plans
  • Potential barriers to clinical adoption
  • Key clinical and scientific risks
The purpose is to provide an independent assessment of the clinical proposition and the strength of the evidence supporting it.

Ways to Work Together

The scope of consultancy can be tailored to the stage and requirements of an individual project.
  • Scientific plausibility

Independent assessment of a specific product, clinical question, study protocol, evidence package or development strategy.

  • Strategic Advisory Consultation

Focused clinical and methodological advice relating to research design, product development, evidence generation, clinical positioning or evaluation strategy.

  • Project Consultancy

Ongoing clinical or academic input into a defined research, product-development or clinical-evaluation programme.

  • Scientific Advisory Boards

Participation in scientific, clinical and strategic advisory boards for pharmaceutical, MedTech, FemTech and healthcare organisations.

  • Long-Term Clinical Advisory Roles

Participation in scientific, clinical and strategic advisory boards for pharmaceutical, MedTech, FemTech and healthcare organisations.

Who I Work With

I welcome collaborations with:
  • Universities and academic research groups
  • Pharmaceutical and biotechnology companies
  • MedTech and medical-device companies
  • FemTech organisations
  • Digital-health companies
  • Healthcare start-ups and scale-ups
  • NHS and healthcare organisations
  • Research funders
  • Investors and organisations undertaking clinical and scientific due diligence

Discuss a Project

If you are developing a healthcare technology, planning a clinical study, evaluating an intervention or seeking independent clinical and academic input, please get in touch. An initial enquiry should ideally include a brief description of the organisation or project, its current stage of development and the areas where specialist input is required.

Stay in touch

Follow my new updates and outputs on the following professional platforms
  1. For any virtual clinical consultations, please contact me using this form
  2. For face to face clinical consultations, please contact me via any of the clinics I practice at. 
  3. For academic queries, collaboration proposals, please contact me on the EVIE group portal.